Dogansen SC, et al. - The goal of this research was to gauge the baseline T2-weighted signal intensity (T2-WSI) of functional pituitary adenomas (FPAs) and to analyze the correlation of baseline T2-WSI with clinical features, histopathologic granulation patterns, and response to treatment in patients with acromegaly, prolactinomas, and Cushing’s disease (CD). A better response to somatostatin analogues (SSAs) was illustrated by baseline hypointense somatotroph adenomas. In contrast, hypointensity exhibited a connection with dopamine agonist (DA) resistance in females with prolactinomas.